TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Govt confirms one jab-related death

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Tribune News Service

Advertisement

New Delhi, June 15

Advertisement

India on Tuesday reported its first vaccine-related death involving a 68-year-old man who suffered a severe allergic reaction after receiving Covishield.

One death was confirmed after the National AEFI Committee studied 31 adverse events following immunization, which included 28 fatalities. The 68-year-old suffered anaphylaxis, a severe allergic reaction. The other 27 deaths were found unrelated to vaccines. All these people had received Covishield.

Advertisement

The government said risks of vaccination were miniscule as against the benefits and a “nano incident of one death after the administration of over 26 crore doses” should not be read out of perspective.

“After the administration of 23.5 crore doses as of two days ago, there were 488 deaths (0.0002%). Not all adverse events following immunization (AEFIs) are vaccine-related,” said the Health Ministry.

Advertisement
Show comments
Advertisement